oxyquinoline has been researched along with Ovarian Neoplasms in 3 studies
Oxyquinoline: An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.
quinolin-8-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One approach in the treatment of ovarian cancer patients involves the infusion of autologous T lymphocytes coupled with a bispecific monoclonal antibody MOv18/anti-CD3 (biMAb OC/TR), which recognizes a 38-kDa glycoprotein expressed on ovarian carcinomas and the CD3 T cell receptor." | 1.30 | Comparison of three different methods for radiolabelling human activated T lymphocytes. ( Arienti, F; Bogni, A; Bombardieri, E; Botti, C; Canevari, S; Crippa, F; Lombardo, C; Maffioli, L; Massaron, S; Negri, DR; Nerini-Molteni, S; Pascali, C; Ramakrishna, V; Remonti, F; Seregni, E, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botti, C | 1 |
| Negri, DR | 1 |
| Seregni, E | 1 |
| Ramakrishna, V | 1 |
| Arienti, F | 1 |
| Maffioli, L | 1 |
| Lombardo, C | 1 |
| Bogni, A | 1 |
| Pascali, C | 1 |
| Crippa, F | 1 |
| Massaron, S | 1 |
| Remonti, F | 1 |
| Nerini-Molteni, S | 1 |
| Canevari, S | 1 |
| Bombardieri, E | 1 |
| Volfson, NI | 1 |
| Vol'fson, NI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the CIRCULATE Catheter for Transcoronary Administration of Pharmacologic and Cell-based Agents[NCT04703751] | 10 participants (Anticipated) | Interventional | 2022-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for oxyquinoline and Ovarian Neoplasms
| Article | Year |
|---|---|
Comparison of three different methods for radiolabelling human activated T lymphocytes.
Topics: Cell Death; Cell Survival; Cells, Cultured; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeox | 1997 |
On the genesis of granulosa-cell ovarian tumors. Experimental data.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Female; Granulosa Cell Tumor; Hexestrol; Mic | 1976 |
[The genesis of experimental granulosa cell tumors of the ovaries].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Female; Granulosa Cell Tumor; Hexestrol; Mic | 1976 |